Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

National Medicaid Reporting Format Needed To Avoid 340B 'Double Dipping' – Manufacturers

This article was originally published in The Pink Sheet Daily

Executive Summary

In response to CMS' proposed rule on Medicaid managed care, biopharma associations say that the only way to avoid Medicaid and 340B 'double dipping' on drug discounts is to require that all state Medicaid programs have a uniform reporting standard for drug utilization data.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst